Acceleration of osteoblast differentiation by a novel osteogenic compound, DMP-PYT, through activation of both the BMP and Wnt pathways
Open Access
- 16 August 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-10
Abstract
Osteoblast differentiation is regulated through the successive activation of signaling molecules by a complex interplay of extracellular signals such as bone morphogenetic protein (BMP) and Wnt ligands. Numerous studies have identified natural as well as synthetic compounds with osteogenic activity through the regulation of either BMP/SMADs or the Wnt/β-catenin pathway. Here, we attempted to isolate small molecules that concurrently activated both SMADs and β-catenin, which led to the discovery of a novel potent osteogenic compound, DMP-PYT. Upon BMP2 stimulation, DMP-PYT substantially increased osteoblast differentiation featured by enhanced expression of osteoblast-specific genes and accelerated calcification through activation of BMPs expression. DMP-PYT promoted BMP2-induced SMAD1/5/8 phosphorylation and β-catenin expression, the latter in a BMP2-independent manner. DMP-PYT alone enhanced nuclear localization of β-catenin to promote the DNA-binding and transcriptional activity of T-cell factor, thereby resulting in increased osteoblast differentiation in the absence of BMP2. Most importantly, DMP-PYT advanced skeletal development and bone calcification in zebrafish larvae. Conclusively, DMP-PYT strongly stimulated osteoblast differentiation and bone formation in vitro and in vivo by potentiating BMP2-induced activation of SMADs and β-catenin. These results suggest that DMP-PYT may have beneficial effects for preventing and for treating osteoporosis.Keywords
This publication has 29 references indexed in Scilit:
- Novel diether compounds inhibiting differentiation of osteoclastsArchives of Pharmacal Research, 2015
- Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unitBoneKEy Reports, 2014
- TGF-β and BMP Signaling in Osteoblast Differentiation and Bone FormationInternational Journal of Biological Sciences, 2012
- Building strong bones: molecular regulation of the osteoblast lineageNature Reviews Molecular Cell Biology, 2011
- Drugs for the management of osteoporosis: a review.2011
- Smad2 functions as a co-activator of canonical Wnt/β-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300Cellular Signalling, 2008
- Integrating Patterning Signals: Wnt/GSK3 Regulates the Duration of the BMP/Smad1 SignalCell, 2007
- Endogenous Production of TGF-β Is Essential for Osteoclastogenesis Induced by a Combination of Receptor Activator of NF-κB Ligand and Macrophage-Colony- Stimulating FactorThe Journal of Immunology, 2000
- Localization of RANKL (receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissuesBone, 1999
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997